These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10933902)

  • 21. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003.
    National Institutes of Health Recombinant DNA Advisory Committee
    Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317
    [No Abstract]   [Full Text] [Related]  

  • 22. Remarks for the RAC Committee meeting of January 14, 1993, regarding compassionate use exemption.
    Healy B
    Hum Gene Ther; 1993 Apr; 4(2):195-7. PubMed ID: 8494929
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy death--"everyone has to share in the guilt".
    Jenks S
    J Natl Cancer Inst; 2000 Jan; 92(2):98-100. PubMed ID: 10639505
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene therapy trials face further scrutiny.
    Greener M
    Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulatory concerns in human gene therapy.
    Epstein SL
    Hum Gene Ther; 1991; 2(3):243-9. PubMed ID: 1751592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols.
    Scharschmidt T; Lo B
    Hum Gene Ther; 2006 Apr; 17(4):448-54. PubMed ID: 16610932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 28. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy in the United States: a five-year status report.
    Ross G; Erickson R; Knorr D; Motulsky AG; Parkman R; Samulski J; Straus SE; Smith BR
    Hum Gene Ther; 1996 Sep; 7(14):1781-90. PubMed ID: 8886849
    [No Abstract]   [Full Text] [Related]  

  • 30. Moral authority.
    Nature; 2013 Jun; 498(7452):5-6. PubMed ID: 23745195
    [No Abstract]   [Full Text] [Related]  

  • 31. Procedures to be followed for expedited review of single patient protocols -- recommendations of the RAC, March 2, 1993.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1993 Jun; 4(3):307. PubMed ID: 11643143
    [No Abstract]   [Full Text] [Related]  

  • 32. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 33. NIH Recombinant DNA Advisory Committee data management report. March 12, 1999.
    Hum Gene Ther; 1999 Jun; 10(9):1577-89. PubMed ID: 10395382
    [No Abstract]   [Full Text] [Related]  

  • 34. Conflict at the RAC.
    Culliton BJ
    Science; 1990 Apr; 298(4952):159. PubMed ID: 11653881
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant DNA research; advisory committee meeting and proposed action under guidelines; notices.
    U.S. National Institutes of Health
    Fed Regist; 1986 Jun; 51(122):23210-1. PubMed ID: 11655768
    [No Abstract]   [Full Text] [Related]  

  • 36. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector.
    Podsakoff GM
    Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant DNA Advisory Committee: minutes of meeting, 10-11 Feb 1992.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1992 Oct; 3(5):563-91. PubMed ID: 11643034
    [No Abstract]   [Full Text] [Related]  

  • 38. Gene therapy setback.
    Beardsley T
    Sci Am; 2000 Feb; 282(2):36-7. PubMed ID: 10710784
    [No Abstract]   [Full Text] [Related]  

  • 39. Death but one unintended consequence of gene-therapy trial.
    Sibbald B
    CMAJ; 2001 May; 164(11):1612. PubMed ID: 11402803
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical medicine. FDA to release data on gene therapy trials.
    Kaiser J
    Science; 2001 Jan; 291(5504):572-3. PubMed ID: 11229395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.